Back to Search
ADNAN MUNKARAH, M.D.
M.D.
Gynecologic Oncology Physician
NPI: 1629166582IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
4301406838(MI)
Education
OTHER
Class of 1985
Research & Publications (20)
The effects of combining docetaxel and cyclooxygenase-2 inhibitors on proliferation and apoptosis in epithelial ovarian cancer.
PMID 17667594·Anticancer Drugs·2007
8-other
COX-2: a protein with an active role in gynecological cancers.
PMID 15711411·Curr Opin Obstet Gynecol·2005
6-review
Critical evaluation of secondary cytoreduction in recurrent ovarian cancer.
PMID 15491746·Gynecol Oncol·2004
6-review
Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells.
PMID 12648598·Gynecol Oncol·2003
8-other
Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer.
PMID 11330956·Gynecol Oncol·2001
8-other
Does secondary surgical cytoreduction improve survival in women with advanced ovarian cancer?
PMID 16264930·Nat Clin Pract Oncol·2005
8-other
Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer.
PMID 19621391·Int J Cancer·2010
7-preclinical
Impact of microsatellite instability (MSI) on survival in high grade endometrial carcinoma.
PMID 19275958·Gynecol Oncol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2799 W GRAND BLVD, HENRY FORD HOSPITAL, K BUILDING- 9TH FLOOR
DETROIT, MI 48202 - Phone
- (313) 916-2465
Quick Facts
- NPI
- 1629166582
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile